Evidence map›Paper›PMID 38599619›Full record

ArticleApplied clinical informatics2024

Provider Perceptions of an Electronic Health Record Prostate Cancer Screening Tool.

Sigrid V Carlsson, Mark Preston, Andrew Vickers, Deepak Malhotra, Behfar Ehdaie, Michael Healey, Adam S Kibel

Abstract read
In one paragraph

Article in Applied clinical informatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Why aren't they used? Systematic review of barriers to implementation of clinical decision support systems for early cancer detection in primary care.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026
    Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sigrid V CarlssonUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
Mark PrestonDivision of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Andrew VickersDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
Deepak MalhotraOrganizations, and Markets Unit, Harvard Business School, Boston, Massachusetts, United States.
Behfar EhdaieUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, United States.
Michael HealeyBrigham and Women's Hospital Primary Care, Brigham and Women's Hospital, Boston, Massachusetts, United States.
Adam S KibelDivision of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Improving shared decision making in cancer screeningK22CA234400 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI CARLSSON, SIGRID · 2019 to 2021
$621k
NCI NIH HHS K22 CA234400NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

objectivesWe conducted a focus group to assess the attitudes of primary care physicians (PCPs) toward prostate-specific antigen (PSA)-screening algorithms, perceptions of using decision support tools, and features that would make such tools feasible to implement.

methodsA multidisciplinary team (primary care, urology, behavioral sciences, bioinformatics) developed the decision support tool that was presented to a focus group of 10 PCPs who also filled out a survey. Notes and audio-recorded transcripts were analyzed using Thematic Content Analysis.

resultsThe survey showed that PCPs followed different guidelines. In total, 7/10 PCPs agreed that engaging in shared decision-making about PSA screening was burdensome. The majority (9/10) had never used a decision aid for PSA screening. Although 70% of PCPs felt confident about their ability to discuss PSA screening, 90% still felt a need for a provider-facing platform to assist in these discussions. Three major themes emerged: (1) confirmatory reactions regarding the importance, innovation, and unmet need for a decision support tool embedded in the electronic health record; (2) issues around implementation and application of the tool in clinic workflow and PCPs' own clinical bias; and (3) attitudes/reflections regarding discrepant recommendations from various guideline groups that cause confusion.

conclusionThere was overwhelmingly positive support for the need for a provider-facing decision support tool to assist with PSA-screening decisions in the primary care setting. PCPs appreciated that the tool would allow flexibility for clinical judgment and documentation of shared decision-making. Incorporation of suggestions from this focus group into a second version of the tool will be used in subsequent pilot testing.

Indexed as

Physicians, Primary CareProstatic NeoplasmsEarly Detection of CancerElectronic Health RecordsHumansMaleMass ScreeningPractice Patterns, Physicians'Prostate-Specific AntigenProstate-Specific Antigen

Identifiers

PMID38599619
PMCPMC11006557

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.